MedPath

A research study in Colombia to test an intervention called DIALOG+, designed to improve care for people living in the community with severe mental illness

Not Applicable
Completed
Conditions
Patients with severe mental illness (including psychosis, bipolar disorder and severe depression)
Mental and Behavioural Disorders
Registration Number
ISRCTN83333181
Lead Sponsor
Queen Mary University of London
Brief Summary

2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/31200671/ (added 11/08/2022)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
173
Inclusion Criteria

1. Primary diagnosis of severe mental illness (psychosis, bipolar disorder and/or severe depression) ICD F20-29, F31, F32
2. Aged 18-65 years old
3. Attending clinic for at least 6 months
4. Scores 5 or below on the MANSA scale
5. Capacity to provide informed consent

Exclusion Criteria

1. Does not meet inclusion criteria
2. Primary diagnosis of substance-use disorder
3. Diagnosis of dementia or organic psychosis
4. An inpatient at the time of recruitment
5. Participating in another study being conducted by this or another research group

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality of life, measured using the Manchester Short Assessment of Quality of Life (MANSA) measured at baseline, 6 months (post intervention) and 12 months
Secondary Outcome Measures
NameTimeMethod
<br> Measured at baseline, 6 months (post intervention) and 12 months:<br> 1. Objective social functioning, measured with the objective social outcome index (SIX)<br> 2. Symptoms, measured with the Brief Psychiatric Rating Scale (BPRS)<br> 3. Service use, measured with adapted Client Service Receipt Inventory (CSRI)<br>
© Copyright 2025. All Rights Reserved by MedPath